Key Takeaways
- • Intellectia AI's simulated tracker reports a +133.12% annualized return for a portfolio modeled on Blackstone Alternative Investment Advisors LLC's 13F holdings.
- • The Defense sector accounts for 34.86% of the simulated portfolio, described as its cornerstone position.
- • The remaining capital is allocated across Medical Biology and other industries, according to the tracker.
- • The tracker uses the top 20 disclosed 13F holdings, rebalanced periodically, with a 45-day disclosure lag.
- • The page is explicitly illustrative and not investment advice.
Summary
Intellectia AI published a simulated stock portfolio tracker built on holdings disclosed by Blackstone Alternative Investment Advisors LLC in institutional 13F filings. The tracker reports an annualized return of +133.12%, though the page's headline performance display shows a 0% figure alongside it, so the reported metrics should be read with caution.
According to the tracker, the Defense sector represents 34.86% of the modeled portfolio and serves as its principal position. The remaining allocation is spread across Medical Biology and other industries. The page does not name the individual securities, their weightings, or the total portfolio value (AUM); its FAQ entries on holding count, recent performance, and AUM appear without answers.
Methodology is described in the disclaimer. The simulation selects the top 20 holdings from 13F filings, excludes positions beyond that, weights the remainder by relative proportion, and rebalances periodically to reflect updated filings. Because 13F disclosures lag by about 45 days, the tracker may not reflect current positioning. The publisher states that the portfolio is for illustrative purposes only, does not constitute investment advice, and that past performance is not indicative of future results.
For institutional readers, the page offers limited decision-relevant information. It does not disclose a fund launch, allocation change, or manager action by Blackstone Alternative Investment Advisors LLC, and it relies on a derivative backtest rather than reported filings or company statements.
According to the tracker, the Defense sector represents 34.86% of the modeled portfolio and serves as its principal position. The remaining allocation is spread across Medical Biology and other industries. The page does not name the individual securities, their weightings, or the total portfolio value (AUM); its FAQ entries on holding count, recent performance, and AUM appear without answers.
Methodology is described in the disclaimer. The simulation selects the top 20 holdings from 13F filings, excludes positions beyond that, weights the remainder by relative proportion, and rebalances periodically to reflect updated filings. Because 13F disclosures lag by about 45 days, the tracker may not reflect current positioning. The publisher states that the portfolio is for illustrative purposes only, does not constitute investment advice, and that past performance is not indicative of future results.
For institutional readers, the page offers limited decision-relevant information. It does not disclose a fund launch, allocation change, or manager action by Blackstone Alternative Investment Advisors LLC, and it relies on a derivative backtest rather than reported filings or company statements.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.